DataMeds AI Earnings
NASDAQ: MEDSHealth CareOther PharmaceuticalsUSD
1.34+0.6123 (+84.14%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
DataMeds AI earnings summary
In its most recent report on Nov 18, 2026 (Sep/2026), MEDS posted EPS of $2.72. Revenue for the quarter was $2.7 million. Quarterly EPS is down 90.2% from the same quarter a year earlier.
Summary generated from market data by MetaCap's automated system. Methodology
MEDS earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Nov 18, 2026 | — | $2.72 | — | — |
| Nov 13, 2026 | — | $-1.18 | — | +80.1% |
| Aug 17, 2026 | — | $-7.13 | — | — |
| May 19, 2026 | — | $-0.07 | — | — |
| Mar 20, 2026 | — | $27.66 | — | — |
| Nov 19, 2025 | — | $-23.07 | — | — |
| Aug 19, 2025 | — | $-5.40 | — | — |
| May 12, 2025 | — | $-0.62 | — | — |
| Mar 25, 2025 | — | $-0.10 | — | — |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.